National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey
No Thumbnail Available
Date
2011-06
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Bu çalışma, 11-15 Haziran 2011 tarihleri arasında İstanbul[Türkiye]’da düzenlenen 30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)’da bildiri olarak sunulmuştur.
Keywords
Allergy, Immunology
Citation
Dursun, A. vd. (2011). "National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey". Allergy, 66(Supplement 94), Special Issue SI, 675-676.